V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16686993 | 330035176 | EE813 | 113 | X724 | 1 | 2017-04-29 | IRINOTECAN | 330005891 | 330003704 | 330006929 |
| 16686994 | 330035176 | EE813 | 2.05 | X724 | 2 | 2017-04-29 | STEROID | 330005891 | 330003704 | 330006929 |
| 16686995 | 330035177 | EGENG | 4900 | X724 | 2 | 2018-07-21 | NOT CHEMO | 330005985 | 330003721 | 330006946 |
| 16686996 | 330035177 | EE813 | 48 | X724 | 1 | 2018-07-21 | VINCRISTINE | 330005985 | 330003721 | 330006946 |
| 16686997 | 330035178 | EEI00 | 125 | X724 | 2 | 2015-07-13 | STEROID | 330006006 | 330003726 | 330006951 |
| 16686998 | 330035179 | EEI00 | 60 | null | 1 | 2016-07-15 | CISPLATIN | 330006017 | 330003733 | 330006955 |
| 16686999 | 330035180 | EEI00 | 150 | X721 | 1 | 2018-03-01 | NOT CHEMO | 330007179 | 330012763 | 330006975 |
| 16687000 | 330035180 | EDZ01 | 200 | X721 | 1 | 2018-03-01 | VINBLASTINE | 330007179 | 330012763 | 330006975 |
| 16687001 | 330035180 | ELW | 20 | X721 | 1 | 2018-03-01 | CETUXIMAB | 330007179 | 330012763 | 330006975 |
| 16687002 | 330035181 | ELW | 450 | null | 1 | 2016-02-06 | CETUXIMAB | 330007251 | 330008035 | 330006992 |
| 16687003 | 330035181 | EGENG | 2 | null | 1 | 2016-02-12 | ETOPOSIDE | 330007251 | 330008035 | 330006992 |
| 16687004 | 330035181 | ELW | 192 | X721 | 1 | 2016-02-12 | PACLITAXEL | 330007251 | 330008035 | 330006992 |
| 16687005 | 330035182 | EE813 | 4000 | X724 | 5 | 2019-03-24 | STEROID | 330007328 | 330003784 | 330007004 |
| 16687006 | 330035183 | EE813 | 0 | X721 | 1 | 2016-02-01 | STEROID | 330007357 | 330003790 | 330007010 |
| 16687007 | 330035183 | EE813 | 200 | X723 | 1 | 2016-02-20 | TEMOZOLOMIDE | 330007357 | 330003790 | 330007010 |
| 16687008 | 330035183 | EZP01 | 50 | X723 | 1 | 2016-05-14 | CETUXIMAB | 330007357 | 330003790 | 330007010 |
| 16687009 | 330035184 | EGQ01 | 10 | null | 1 | 2018-06-24 | ETOPOSIDE | 330007378 | 330003795 | 330007014 |
| 16687010 | 330035186 | EGQ01 | 10 | X724 | 1 | 2016-06-01 | CYCLOPHOSPHAMIDE | 330007437 | 330003811 | 330007029 |
| 16687011 | 330035186 | EE813 | 25 | X722 | 1 | 2016-06-02 | TOPOTECAN | 330007437 | 330003811 | 330007029 |
| 16687012 | 330035186 | ED617 | 98 | X729 | 1 | 2016-06-03 | FLUDARABINE | 330007437 | 330003811 | 330007029 |
| 16687013 | 330035187 | EE813 | 8 | X721 | 1 | 2018-06-08 | SUNITINIB | 330007437 | 330003811 | 330007031 |
| 16687014 | 330035187 | EE813 | 2 | null | 2 | 2018-06-08 | TOPOTECAN | 330007437 | 330003811 | 330007031 |
| 16687015 | 330035187 | EW100 | null | X723 | 1 | 2018-06-15 | METHOTREXATE | 330007437 | 330003811 | 330007031 |
| 16687016 | 330035187 | EOG20 | 5600 | X721 | 1 | 2018-06-15 | CETUXIMAB | 330007437 | 330003811 | 330007031 |
| 16687017 | 330035187 | EKD02 | 60 | X723 | 2 | 2018-06-15 | IFOSFAMIDE | 330007437 | 330003811 | 330007031 |
| 16687018 | 330035187 | EW100 | 300 | X721 | 1 | 2018-06-15 | CARBOPLATIN | 330007437 | 330003811 | 330007031 |
| 16687019 | 330035188 | EE813 | 4 | X721 | 1 | 2014-08-06 | MELPHALAN | 330007480 | 330003823 | 330007038 |
| 16687020 | 330035188 | Haqrsvarq | 170 | X729 | 2 | 2014-08-07 | RITUXIMAB | 330007480 | 330003823 | 330007038 |
| 16687021 | 330035190 | EE813 | 30 | X724 | 5 | 2015-03-07 | FLUOROURACIL | 330007588 | 330003859 | 330007073 |
| 16687022 | 330035191 | EOI | 120 | X721 | 1 | null | BORTEZOMIB | 330007855 | 330003922 | 330007132 |
| 16687023 | 330035191 | Haqrsvarq | 2 | null | 1 | null | DOXORUBICIN | 330007855 | 330003922 | 330007132 |
| 16687024 | 330035193 | EOI | 20 | X721 | 1 | 2016-08-26 | BORTEZOMIB | 330007980 | 330003947 | 330007150 |
| 16687025 | 330035193 | EQ3 | 164 | X729 | 5 | 2016-08-26 | CAPECITABINE | 330007980 | 330003947 | 330007150 |
| 16687026 | 330035194 | EQ8 | 555 | null | 2 | 2013-10-27 | CYTARABINE | 330008157 | 330003992 | 330007203 |
| 16687027 | 330035195 | EQ8 | 140 | X724 | 1 | 2015-03-14 | NOT CHEMO | 330008208 | 330004007 | 330007214 |
| 16687028 | 330035196 | EQ8 | 86 | X724 | 1 | 2015-08-01 | CYTARABINE | 330008299 | 330008195 | 330007232 |
| 16687029 | 330035197 | EQ8 | 6300 | N/A | 1 | 2017-06-26 | PEMBROLIZUMAB | 330008309 | 330010448 | 330007237 |
| 16687030 | 330035197 | EK1PP | 2 | X723 | 1 | 2017-07-02 | CYCLOPHOSPHAMIDE | 330008309 | 330010448 | 330007237 |
| 16687031 | 330035197 | ECL01 | 487.5 | X724 | 2 | 2017-07-02 | CISPLATIN | 330008309 | 330010448 | 330007237 |
| 16687032 | 330035197 | EOI | 5200 | X724 | 2 | 2017-07-02 | PEMETREXED | 330008309 | 330010448 | 330007237 |
| 16687033 | 330035197 | EKU01 | 22 | null | 1 | 2017-07-03 | PACLITAXEL | 330008309 | 330010448 | 330007237 |
| 16687034 | 330035198 | EUH | 150 | X724 | 1 | 2016-07-05 | NOT CHEMO | 330008594 | 330004079 | 330007276 |
| 16687035 | 330035199 | EX950 | 8 | X724 | 1 | 2018-06-03 | EPIRUBICIN | 330008614 | 330012395 | 330007279 |
| 16687036 | 330035199 | EWR01 | 50 | X721 | 2 | 2018-06-03 | METHOTREXATE | 330008614 | 330012395 | 330007279 |
| 16687037 | 330035200 | ERS12 | 100 | X729 | 1 | 2016-10-30 | CETUXIMAB | 330008744 | 330004090 | 330007293 |
| 16687038 | 330035202 | EE813 | 720 | X724 | 3 | 2014-11-25 | CYTARABINE | 330008859 | 330004101 | 330007304 |
| 16687039 | 330035202 | E1UZ0 | 110 | X724 | 1 | 2014-11-25 | CISPLATIN | 330008859 | 330004101 | 330007304 |
| 16687040 | 330035203 | EKCPC | 0 | X721 | 3 | 2015-05-29 | MESNA | 330008887 | 330004103 | 330007308 |
| 16687041 | 330035203 | EUJ37 | 30 | X724 | 1 | 2015-05-29 | RITUXIMAB | 330008887 | 330004103 | 330007308 |
| 16687043 | 330035205 | ELW | 192 | X724 | 1 | 2018-04-28 | NOT CHEMO | 330008953 | 330004120 | 330007320 |